ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1492

A Permissive Factor of Anti-Ro+ Mothers of Neonatal Lupus Children Is Linked to Overt SLE Associated with Immunity to a Gut Commensal

Robert Clancy1, Miranda Marion2, Hannah Ainsworth2, Miao Chang1, Timothy Howard3, Peter Izmirly4, Mala Masson5, Jill Buyon6 and Carl Langefeld7, 1NYU Grossman School of Medicine, New York, NY, 2Wake Forest University, Winston-Salem, NC, 3Wake Forest University, Quakertown, NC, 4New York University School of Medicine, New York, NY, 5NYU Grossman School Medicine, New York, NY, 6NYU School of Medicine, New York, NY, 7Wake Forest University, Winston Salem, NC

Meeting: ACR Convergence 2021

Keywords: Autoantibody(ies), autoimmune diseases, Biomarkers, microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: SLE – Etiology & Pathogenesis Poster (1480–1506)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Unknown factors trigger the transition of anti-Ro+ mothers of neonatal lupus (NL) children from preclinical autoimmunity to clinical disease. One candidate may be the gut microbiome with specific taxa serving as environmental triggers contributing to clinical phenotype. We have previously reported differential abundances between anti-Ro+ mothers versus healthy controls (HC), noting a bloom in relative abundance of protective commensals including the genus Bacteroides. This taxon promotes tolerance at the interface of mucosal immunity. This study was initiated to test for associations of abundance of Bacteroides, and disease groups and for associations of anti-Ro titers.

Methods: Subjects included 125 RRNL mothers and 23 healthy controls. Stool microbiome of anti-Ro+ women in RRNL (asymptomatic and undifferentiated autoimmune syndrome (Asym/UAS), and SLE, SS, SS/SLE (SS/SLE)), and healthy controls (HC) were processed using 16S ribosomal RNA sequencing and use of a standard informatics pipeline. Tests for differential relative abundances of stool taxa applied compositional data analysis methods, linear models and adjustments for multiple comparisons. Assessments also included titers and specificities of anti-Ro using ELISA.

Results: The relative abundances varied as a function of clinical severity (HC < Asym/UAS < SS/SLE) shown across 13 genera (FDR < 0.05) including Bacteroides. Importantly, these ordered differences were maintained through the taxonomic hierarchy to Bacteroides (Figure 1) with the exception at species level Bacteroides vulgatus whereby relative median abundance reported at HC < SS/SLE < Asym/UAS (Figure 2), a finding that supported a focus on unique features of Asym/UAS that relate to Bacteroides. The initial analysis involved a comparison of Asym/UAS relative to HC. Applying multiple test correction, we observed an association of Bacteroidetes (P< 0.0001), as well as taxa at subsequent lower taxonomic levels including Bacteroides (P= 2.45 x 10-7), reflecting a higher relative abundance in Asym/UAS relative to HC. A subsequent analysis involved associations of Bacteroides relating to anti-Ro autoantibodies. While high titers of anti-Ro60 IgG and IgA as well as anti-Ro52 IgG and IgA titers were present in all NL mothers and absent in HC, there was an association between anti-Ro and Bacteroides relative abundance with an observed genus-by-disease interaction (P=0.0045; β=0.43 SE(β)=0.15) for Ro52 IgA levels. Specifically, with anti-Ro as an outcome, levels were relatively constant for individuals diagnosed with SS/SLE but decreased with abundance in Asym/UAS (P< 0.005, Figure 3). These data suggest that the abundance of Bacteroides may influence features that are a distinction of SS/SLE such as high levels of autoantibody, which in this study was favored by low abundance of Bacteroides.

Conclusion: The data provide intriguing initial evidence that a permissive factor in NL anti-Ro+ mothers which links overt SLE immunity to a gut commensal, Bacteroides vulgatus.

Figure1_RoAb.jpeg”Figure 1. Analysis of the stool genus, Bacteroides, meeting statistical significance (FDR P-value < 0.05) using the taxonomic stepdown method

Figure2_RoAb.jpeg”Figure 2. Species does not share ordinal significance, a feature that was evident at family and genus levels.

Figure 3_autoabs.jpeg”Figure 3. With anti-Ro52 IgA as an outcome, levels of autoantibody decreased with abundance in Asym/UAS subjects (P < 0.005).


Disclosures: R. Clancy, None; M. Marion, None; H. Ainsworth, None; M. Chang, None; T. Howard, None; P. Izmirly, Momenta/Janssen, 1; M. Masson, None; J. Buyon, Bristol Myers Squibb, 1, GlaxoSmithKline, 2, Janssen, 2, Ventus, 2, Equillium, 2; C. Langefeld, None.

To cite this abstract in AMA style:

Clancy R, Marion M, Ainsworth H, Chang M, Howard T, Izmirly P, Masson M, Buyon J, Langefeld C. A Permissive Factor of Anti-Ro+ Mothers of Neonatal Lupus Children Is Linked to Overt SLE Associated with Immunity to a Gut Commensal [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-permissive-factor-of-anti-ro-mothers-of-neonatal-lupus-children-is-linked-to-overt-sle-associated-with-immunity-to-a-gut-commensal/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-permissive-factor-of-anti-ro-mothers-of-neonatal-lupus-children-is-linked-to-overt-sle-associated-with-immunity-to-a-gut-commensal/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology